AGREEMENT AND PLAN OF
MERGER
PER-SE TECHNOLOGIES,
INC.
Dated as of November 5,
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
1
|
|
SECTION 1.03. Effective Time
|
|
|
2
|
|
SECTION 1.04. Effects of the Merger
|
|
|
2
|
|
SECTION 1.05. Certificate of Incorporation and
By-laws
|
|
|
2
|
|
SECTION 1.06. Directors and Officers of the
Surviving Corporation
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EFFECT OF THE MERGER ON THE CAPITAL STOCK OF THE
CONSTITUENT
|
CORPORATIONS; EXCHANGE OF
CERTIFICATES
|
|
|
|
|
|
|
SECTION 2.01. Effect on Capital Stock
|
|
|
3
|
|
SECTION 2.02. Treatment of Company Stock
Options; Company RSUs; Company Deferred Stock Units
|
|
|
3
|
|
SECTION 2.03. Dissenting Shares
|
|
|
6
|
|
SECTION 2.04. Exchange of
Certificates
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
REPRESENTATIONS AND WARRANTIES OF THE
COMPANY
|
|
|
|
|
|
|
SECTION 3.01. Organization, Standing and
Corporate Power; Subsidiaries
|
|
|
8
|
|
SECTION 3.02. Certificate of Incorporation and
Bylaws
|
|
|
9
|
|
SECTION 3.03. Capitalization
|
|
|
9
|
|
|
|
|
|
11
|
|
SECTION 3.05. No Conflict; Required Filings and
Consents
|
|
|
11
|
|
SECTION 3.06. Company SEC Documents; Financial
Statements; No Undisclosed Liabilities
|
|
|
12
|
|
SECTION 3.07. Absence of Certain Changes or
Events
|
|
|
14
|
|
|
|
|
|
15
|
|
SECTION 3.09. Material Contracts
|
|
|
16
|
|
SECTION 3.10. Government Contracts
|
|
|
18
|
|
SECTION 3.11. Permits; Compliance with
Laws
|
|
|
18
|
|
SECTION 3.12. Environmental Matters
|
|
|
20
|
|
SECTION 3.13. Labor Relations and Other
Employment Matters
|
|
|
21
|
|
SECTION 3.14. ERISA Compliance
|
|
|
21
|
|
|
|
|
|
25
|
|
SECTION 3.16. Title to Properties
|
|
|
27
|
|
SECTION 3.17. Intellectual Property
|
|
|
28
|
|
SECTION 3.18. Voting Requirements
|
|
|
30
|
|
|
|
|
|
|
|
SECTION 3.19. Takeover Statutes; Rights
Plans
|
|
|
30
|
|
SECTION 3.20. Proxy Statement
|
|
|
31
|
|
SECTION 3.21. Brokers and Other
Advisors
|
|
|
31
|
|
SECTION 3.22. Opinion of Financial
Advisors
|
|
|
31
|
|
|
|
|
|
31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
REPRESENTATIONS AND WARRANTIES OF
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SECTION 4.01. Organization, Standing and
Corporate Power
|
|
|
32
|
|
|
|
|
|
32
|
|
SECTION 4.03. No Conflict; Required Filings and
Consents
|
|
|
32
|
|
|
|
|
|
33
|
|
SECTION 4.05. Proxy Statement
|
|
|
33
|
|
SECTION 4.06. Interim Operations of Merger
Sub
|
|
|
34
|
|
SECTION 4.07. Capital Resources
|
|
|
34
|
|
|
|
|
|
34
|
|
SECTION 4.09. Voting Requirements
|
|
|
34
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONDUCT OF BUSINESS PENDING THE
MERGER
|
|
|
|
|
|
|
|
|
|
|
SECTION 5.01. Conduct of Business of the Company
Pending the Merger
|
|
|
35
|
|
SECTION 5.02. Advice of Changes
|
|
|
38
|
|
SECTION 5.03. Certain Tax Matters
|
|
|
38
|
|
SECTION 5.04. No Control of Other Party’s
Business
|
|
|
38
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SECTION 6.01. Stockholders Meeting
|
|
|
38
|
|
SECTION 6.02. Proxy Statement
|
|
|
39
|
|
SECTION 6.03. Access to Information;
Confidentiality
|
|
|
39
|
|
SECTION 6.04. No Solicitation
|
|
|
41
|
|
SECTION 6.05. Further Action; Efforts
|
|
|
44
|
|
SECTION 6.06. Directors’ and
Officers’ Indemnification and Insurance
|
|
|
46
|
|
SECTION 6.07. Public Announcements
|
|
|
47
|
|
SECTION 6.08. Stockholder Litigation
|
|
|
48
|
|
SECTION 6.09. Employee Matters
|
|
|
48
|
|
SECTION 6.10. Takeover Laws
|
|
|
49
|
|
- ii -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SECTION 7.01. Conditions to Each Party’s
Obligation to Effect the Merger
|
|
|
49
|
|
SECTION 7.02. Conditions to Obligations of
Parent and Merger Sub
|
|
|
50
|
|
SECTION 7.03. Conditions to Obligation of the
Company
|
|
|
51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TERMINATION, AMENDMENT AND WAIVER
|
|
|
|
|
|
|
|
|
|
|
SECTION 8.01. Termination
|
|
|
51
|
|
SECTION 8.02. Effect of Termination
|
|
|
53
|
|
|
|
|
|
55
|
|
SECTION 8.04. Extension; Waiver
|
|
|
55
|
|
SECTION 8.05. Procedure for Termination or
Amendment
|
|
|
55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SECTION 9.01. Nonsurvival of Representations and
Warranties
|
|
|
55
|
|
SECTION 9.02. Fees and Expenses
|
|
|
55
|
|
|
|
|
|
55
|
|
SECTION 9.04. Definitions
|
|
|
56
|
|
SECTION 9.05. Interpretation
|
|
|
58
|
|
SECTION 9.06. Consents and Approvals
|
|
|
59
|
|
SECTION 9.07. Counterparts
|
|
|
59
|
|
SECTION 9.08. Entire Agreement; No Third-Party
Beneficiaries
|
|
|
59
|
|
SECTION 9.09. GOVERNING LAW
|
|
|
59
|
|
|
|
|
|
59
|
|
SECTION 9.11. Specific Enforcement; Consent to
Jurisdiction
|
|
|
59
|
|
SECTION 9.12. Waiver of Jury Trial
|
|
|
60
|
|
SECTION 9.13. Severability
|
|
|
60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit A Amended and
Restated Certificate of Incorporation of the Surviving
Corporation
|
|
|
|
|
- iii -
|
|
|
|
|
|
2024 Convertible Debentures
|
|
|
10
|
|
|
|
|
|
16
|
|
|
|
|
|
57
|
|
|
|
|
|
46
|
|
|
|
|
|
57
|
|
|
|
|
|
9
|
|
|
|
|
|
3
|
|
|
|
|
|
2
|
|
|
|
|
|
1
|
|
|
|
|
|
1
|
|
|
|
|
|
6
|
|
Commonly Controlled Entity
|
|
|
22
|
|
|
|
|
|
1
|
|
Company Adverse Recommendation
Change
|
|
|
43
|
|
Company Benefit Agreements
|
|
|
16
|
|
|
|
|
|
22
|
|
|
|
|
|
9
|
|
|
|
|
|
2
|
|
|
|
|
|
3
|
|
|
|
|
|
20
|
|
Company Deferred Amount Stock
Unit
|
|
|
5
|
|
Company Deferred Stock Units
|
|
|
5
|
|
Company Disclosure Schedule
|
|
|
8
|
|
|
|
|
|
5
|
|
Company Enhancement Bonus Stock
Unit
|
|
|
5
|
|
Company Intellectual Property
|
|
|
29
|
|
|
|
|
|
29
|
|
|
|
|
|
4
|
|
Company Non-Voting Common Stock
|
|
|
9
|
|
|
|
|
|
22
|
|
|
|
|
|
15
|
|
|
|
|
|
9
|
|
|
|
|
|
39
|
|
Company Registered Intellectual
Property
|
|
|
28
|
|
|
|
|
|
9
|
|
|
|
|
|
9
|
|
|
|
|
|
4
|
|
|
|
|
|
13
|
|
Company Service-Based RSUs
|
|
|
4
|
|
|
|
|
|
30
|
|
|
|
|
|
30
|
|
|
|
|
|
3
|
|
|
|
|
|
10
|
|
Company Stock-Based Awards
|
|
|
10
|
|
Company Stockholder Approval
|
|
|
31
|
|
|
|
|
|
22
|
|
Company-Owned Intellectual
Property
|
|
|
29
|
|
Confidentiality Agreement
|
|
|
41
|
|
|
|
|
|
48
|
|
|
|
|
|
12
|
|
Converted Deferred Stock Unit
|
|
|
5
|
|
|
|
|
|
4
|
|
|
|
|
|
1
|
|
|
|
|
|
6
|
|
|
|
|
|
46
|
|
|
|
|
|
57
|
|
|
|
|
|
2
|
|
|
|
|
|
21
|
|
|
|
|
|
22
|
|
|
|
|
|
12
|
|
|
|
|
|
6
|
|
Federal Health Care Program
|
|
|
20
|
|
Filed Company SEC Documents
|
|
|
13
|
|
|
|
|
|
41
|
|
|
|
|
|
46
|
|
|
|
|
|
22
|
|
|
|
|
|
46
|
|
|
|
|
|
13
|
|
|
|
|
|
18
|
|
|
|
|
|
18
|
|
|
|
|
|
12
|
|
|
|
|
|
21
|
|
Healthcare Information Laws
|
|
|
20
|
|
|
|
|
|
19
|
|
|
|
|
|
12
|
|
Inbound License Agreements
|
|
|
29
|
|
|
|
|
|
29
|
|
|
|
|
|
30
|
|
|
|
|
|
44
|
|
|
|
|
|
23
|
|
|
|
|
|
57
|
|
|
|
|
|
57
|
|
|
|
|
|
12
|
|
|
|
|
|
28
|
|
|
|
|
|
28
|
|
|
|
|
|
9
|
|
|
|
|
|
57
|
|
|
|
|
|
16
|
|
|
|
|
|
1
|
|
|
|
|
|
3
|
|
|
|
|
|
1
|
|
- iv -
|
|
|
|
|
|
|
|
|
|
12
|
|
Notice of Superior Proposal
|
|
|
43
|
|
|
|
|
|
12
|
|
Outbound License Agreements
|
|
|
29
|
|
|
|
|
|
52
|
|
|
|
|
|
28
|
|
|
|
|
|
1
|
|
|
|
|
|
4
|
|
Parent Material Adverse Effect
|
|
|
58
|
|
|
|
|
|
6
|
|
|
|
|
|
19
|
|
|
|
|
|
58
|
|
|
|
|
|
59
|
|
|
|
|
|
31
|
|
Publicly Available Software
|
|
|
30
|
|
|
|
|
|
28
|
|
Registered Intellectual Property
|
|
|
30
|
|
|
|
|
|
21
|
|
|
|
|
|
41
|
|
|
|
|
|
13
|
|
|
|
|
|
13
|
|
|
|
|
|
30
|
|
|
|
|
|
14
|
|
|
|
|
|
1
|
|
|
|
|
|
39
|
|
|
|
|
|
59
|
|
|
|
|
|
42
|
|
|
|
|
|
1
|
|
|
|
|
|
42
|
|
|
|
|
|
27
|
|
|
|
|
|
28
|
|
|
|
|
|
28
|
|
|
|
|
|
54
|
|
|
|
|
|
31
|
|
|
|
|
|
1
|
|
- v -
AGREEMENT AND PLAN OF
MERGER
AGREEMENT AND PLAN
OF MERGER, dated as of November 5, 2006, among MCKESSON
CORPORATION, a Delaware corporation (“ Parent
”), PACKET MERGER SUB INC., a Delaware corporation and a
wholly owned Subsidiary of Parent (“ Merger Sub
”), and PER-SE TECHNOLOGIES, INC., a Delaware corporation
(the “ Company ”).
WHEREAS, the Board
of Directors of each of Parent, Merger Sub and the Company has
approved and declared advisable this Agreement and the merger of
Merger Sub with and into the Company (the “ Merger
”), upon the terms and subject to the conditions set forth in
this Agreement;
WHEREAS, the Board
of Directors of each of Parent and the Company have determined that
it is in the best interests of their respective companies and
stockholders to consummate the Merger provided for herein;
and
WHEREAS, as a
material inducement to Parent to enter into this Agreement, and
simultaneously with the execution of this Agreement, certain
stockholders of the Company (collectively, the “
Stockholder Party ”) are entering into an agreement
with Parent and the Company (the “ Voting Agreement
”) pursuant to which the Stockholder Party has agreed, among
other things, to vote its shares of the Company Common Stock in
favor of the adoption of this Agreement and the Merger.
NOW, THEREFORE, in
consideration of the representations, warranties, covenants and
agreements contained in this Agreement, and subject to the
conditions set forth herein, the parties hereto agree as
follows:
SECTION 1.01.
The Merger . Upon the terms and subject to the conditions
set forth in this Agreement, and in accordance with the General
Corporation Law of the State of Delaware (the “ DGCL
”), Merger Sub shall be merged with and into the Company at
the Effective Time. As a result of the Merger, the separate
corporate existence of Merger Sub shall cease and the Company shall
continue as the surviving corporation of the Merger (the “
Surviving Corporation ”).
SECTION 1.02.
Closing . The closing of the Merger (the “
Closing ”) shall take place at 10:00 a.m., local
time, on a date to be specified by the parties, which shall be no
later than the second Business Day after satisfaction or (to the
extent permitted by applicable Law) waiver of the conditions set
forth in Article VII (other than those conditions that by
their terms are to be satisfied at the Closing, but subject to the
satisfaction or (to the extent permitted by applicable Law) waiver
of those conditions), at the offices of Simpson Thacher &
Bartlett LLP, 425 Lexington Ave., New York, New York 10017, unless
another time, date or place is agreed to in writing by Parent and
the Company. The date on which the Closing occurs is referred to in
this Agreement as the “ Closing Date
”.
SECTION 1.03.
Effective Time . Subject to the provisions of this
Agreement, at the Closing, the parties shall cause the Merger to be
consummated by filing with the Secretary of State of the State of
Delaware a certificate of merger (the “ Certificate of
Merger ”), in such form as required by, and executed and
acknowledged by the parties in accordance with, the relevant
provisions of the DGCL, and shall make all other filings or
recordings required under the DGCL in connection with the Merger.
The Merger shall become effective upon the filing of the
Certificate of Merger with the Secretary of State of the State of
Delaware or at such later time as Parent and the Company shall
agree and shall specify in the Certificate of Merger (the time the
Merger becomes effective being hereinafter referred to as the
“ Effective Time ”).
SECTION 1.04.
Effects of the Merger . The Merger shall have the effects
set forth herein and in the applicable provisions of the DGCL.
Without limiting the generality of the foregoing and subject
thereto, at the Effective Time, all the property, rights,
privileges, immunities, powers and franchises of the Company and
Merger Sub shall vest in the Surviving Corporation and all debts,
liabilities and duties of the Company and Merger Sub shall become
the debts, liabilities and duties of the Surviving
Corporation.
SECTION 1.05.
Certificate of Incorporation and By-laws . (a) The
Restated Certificate of Incorporation of the Company (the “
Company Certificate ”) shall be amended at the
Effective Time so as to read in its entirety as set forth on
Exhibit B hereto and, as so amended, such Company
Certificate shall be the certificate of incorporation of the
Surviving Corporation until thereafter changed or amended as
provided therein and by applicable Law.
(b) At
the Effective Time, and without any further action on the part of
the Company and Merger Sub, the Restated Bylaws of the Company
shall be amended so as to read in their entirety as the Bylaws of
Merger Sub (except that the name of the Surviving Corporation shall
be “Per-Se Technologies, Inc.”) and, as so amended,
shall be the Bylaws of the Surviving Corporation until thereafter
changed or amended as provided therein or by applicable
Law.
SECTION 1.06.
Directors and Officers of the Surviving Corporation .
(a) The directors of Merger Sub immediately prior to the
Effective Time shall be the directors of the Surviving Corporation
until the earlier of their resignation or removal or until their
respective successors are duly elected and qualified, as the case
may be.
(b) The
officers of the Company immediately prior to the Effective Time
shall be the initial officers of the Surviving Corporation, each to
hold office until the earlier of their resignation or removal or
until their respective successors are duly elected and qualified,
as the case may be.
- 2 -
EFFECT OF THE MERGER ON THE
CAPITAL STOCK OF THE CONSTITUENT
CORPORATIONS; EXCHANGE OF CERTIFICATES
SECTION 2.01.
Effect on Capital Stock . At the Effective Time, by virtue
of the Merger and without any action on the part of the holder of
any shares of the Company’s common stock, par value $0.01 per
share (“ Company Common Stock ”), or of any
shares of capital stock of Parent or Merger Sub:
(a) Each
issued and outstanding share of capital stock of Merger Sub shall
be converted into and become one validly issued, fully paid and
nonassessable share of common stock of the Surviving
Corporation;
(b) Each
share of Company Common Stock that is directly owned by the Company
or Parent immediately prior to the Effective Time shall
automatically be canceled and shall cease to exist, and no
consideration shall be delivered in exchange therefor;
provided that, for the avoidance of doubt, no shares of
Company Common Stock that are owned by a direct or indirect
wholly-owned Subsidiary of the Company shall be canceled pursuant
to this Section 2.01(b); and
(c) Each
share of Company Common Stock issued and outstanding immediately
prior to the Effective Time (other than shares to be canceled in
accordance with Section 2.01(b), any Dissenting Shares and any
shares that are owned by a direct or indirect wholly-owned
Subsidiary of the Company, which shall remain outstanding) shall be
converted into the right to receive $28.00 in cash, without
interest (the “ Merger Consideration ”), payable
to the holder thereof upon surrender of such share in the manner
provided in Section 2.04. At the Effective Time, all such
shares of Company Common Stock shall no longer be outstanding and
shall automatically be canceled and shall cease to exist, and each
holder of a certificate which immediately prior to the Effective
Time represented any such shares of Company Common Stock (each, a
“ Certificate ”) shall cease to have any rights
with respect thereto, except the right to receive the Merger
Consideration to be paid in consideration therefor upon surrender
of such Certificate in accordance with Section 2.04(b). The
right of any holder of a Certificate to receive the Merger
Consideration shall be subject to and reduced by the amount of
withholding (if any) that is required to be made under applicable
Tax Law.
SECTION 2.02.
Treatment of Company Stock Options; Company RSUs; Company
Deferred Stock Units . (a) The Company shall provide that,
as of the Effective Time, each option to purchase Company Common
Stock (each, a “ Company Stock Option ”) granted
under any Company Stock Plan which, in each case, is outstanding
immediately prior to the Effective Time (whether vested or
unvested, exercisable or not exercisable), shall be canceled by the
Company, and the holder thereof shall be entitled to receive
promptly following the Effective Time from the Surviving
Corporation, in consideration for such cancellation, an amount
(less the amount of withholding (if any) that is required to be
made under applicable Tax Law) equal to the product of (i) the
excess, if any, of (A) the Merger Consideration over
(B) the exercise price per share of Company Common Stock
subject to such Company Stock Option, multiplied by
(ii) the total number of shares of Company Common Stock
subject to such Company Stock Option.
- 3 -
In the event
that the exercise price of any Company Stock Option is equal to or
greater than the Merger Consideration, such Company Stock Option
shall be canceled without payment therefor and have no further
force or effect.
(b) Except
as provided in Section 2.02(c), the Company shall provide
that, as of the Effective Time, each restricted stock unit granted
under any Company Stock Plan (each, a “ Company RSUs
”) which, in each case, is outstanding immediately prior to
the Effective Time (whether vested or unvested) shall be canceled
by the Company and the holder thereof shall be entitled to receive
promptly following the Effective Time from the Surviving
Corporation, in consideration for such cancellation, an amount
(less the amount of withholding (if any) that is required to be
made under applicable Tax Law) equal to the product of (i) the
Merger Consideration, multiplied by (ii) the total
number of shares of Company Common Stock subject to such Company
RSU.
(c)
(i) Notwithstanding anything herein to the contrary, as soon
as practicable following the date of this Agreement, the Company
shall take such actions as are necessary to cause the Surviving
Corporation as of the Effective Time to assume the obligations of
the Company under the Company’s 2006 Long-Term Incentive Plan
(the “ Company LTIP ”) with respect to Company
RSUs that are service-based restricted stock units (“
Company Service-Based RSUs ”) and the Company’s
board of directors shall adopt such resolutions or take such other
actions as may be required to effect the following:
(A)
At the Effective Time, each Company Service-Based RSU granted by
the Company under the Company LTIP, which is outstanding and which
has not been settled by the issuance of shares of Company Common
Stock immediately prior to the Effective Time, shall cease to
represent a right to receive upon settlement shares of Company
Common Stock and shall instead be assumed by Parent and converted
automatically into a right (a “ Converted RSU ”)
to receive upon settlement (otherwise in accordance with the terms
of the Company LTIP and the agreements evidencing grants
thereunder) such number of shares of common stock, par value $0.01
per share, of Parent (“ Parent Common Stock ”)
as is equal to (I) the number of shares of Company Common
Stock subject to such Company Service-Based RSU immediately prior
to the Effective Time multiplied by (II) the quotient
of (x) the Merger Consideration divided by (y) the
closing price of Parent Common Stock on the Closing
Date.
(B)
As soon as reasonably practicable after the Effective Time, Parent
shall deliver to each holder of a Converted RSU an appropriate
notice evidencing the foregoing assumption of the restricted stock
unit award by Parent. Parent shall comply with the terms of the
Company LTIP and the agreements, subject to the adjustments
pursuant to this Section 2.02(c). Each holder of a Converted
RSU shall be credited with such holder’s service with the
Company or its Subsidiaries for purposes of determining such
holder’s vesting under such Converted RSU.
(ii)
Parent shall take all corporate action necessary to reserve for
issuance a sufficient number of shares of Parent Common Stock for
delivery upon the settlement of Converted RSUs. As soon as
practicable after the Effective Time, Parent
- 4 -
shall file a
registration statement on Form S-8 (or any successor or other
appropriate form) with respect to the shares of Parent Common Stock
subject to the Converted RSUs.
(d)
(i) As soon as practicable following the date of this
Agreement, the Company shall take such actions as are necessary to
cause the Surviving Corporation as of the Effective Time to assume
the obligations of the Company under the Company’s Deferred
Stock Unit Plan (the “ Company DSU Plan ”) with
respect to deferred amount stock units (each a “ Company
Deferred Amount Stock Unit ”) and enhancement bonus stock
units (each a “ Company Enhancement Bonus Stock Unit
” and, together with the Company Deferred Amount Stock Units,
the “ Company Deferred Stock Units ”) and the
Company’s board of directors shall adopt such resolutions or
take such other actions as may be required to effect the
following:
(A) At the
Effective Time, each Company Deferred Stock Unit outstanding under
the Company DSU Plan, which has not been distributed immediately
prior to the Effective Time, shall cease to represent a right to
receive upon distribution shares of Company Common Stock and shall
instead be assumed by Parent and converted automatically into a
right (a “ Converted Deferred Stock Unit ”) to
receive upon distribution (otherwise in accordance with the terms
of the Company DSU Plan) such number of shares Parent Common Stock
as is equal to (I) the number of shares of Company Common
Stock subject to such Company Deferred Stock Unit immediately prior
to the Effective Time multiplied by (II) the quotient
of (x) the Merger Consideration divided by (y) the
closing price of Parent Common Stock on the Closing
Date.
(B) As soon as
reasonably practicable after the Effective Time, Parent shall
deliver to each holder of a Converted Deferred Stock Unit an
appropriate notice evidencing the foregoing assumption by Parent.
Parent shall comply with the terms of the Company DSU Plan and any
related agreements, subject to the adjustments pursuant to this
Section 2.02(d). Each holder of a Converted Deferred Stock
Unit shall be credited with such holder’s service with the
Company or its Subsidiaries for purposes of determining such
holder’s vesting under such Converted Deferred Stock
Unit.
(ii)
Parent shall take all corporate action necessary to reserve for
issuance a sufficient number of shares of Parent Common Stock for
delivery upon the settlement of Converted Deferred Stock Units. As
soon as practicable after the Effective Time, Parent shall file a
registration statement on Form S-8 (or any successor or other
appropriate form) with respect to the shares of Parent Common Stock
subject to the Converted Deferred Stock Units.
(e) Prior
to the Effective Time, the Company shall take all actions necessary
in order to effectuate the provisions of this
Section 2.02.
(f) It
is the intent of the parties that the Converted RSUs and Converted
Deferred Stock Units shall comply with Section 409A of the
Internal Revenue Code of 1986, as amended (the “ Code
”), so as to avoid the imposition of any additional taxes or
penalties in respect of deferred compensation, and that, to the
extent necessary to comply with such section, the provisions of
this Section 2.02 shall be construed in a manner consistent
with such intent and adjusted, to the extent necessary, to avoid a
failure to comply with Section 409A of the Code.
- 5 -
SECTION 2.03.
Dissenting Shares . (a) Shares of Company Common Stock
that are issued and outstanding immediately prior to the Effective
Time and that are held by holders that have properly demanded and
perfected their appraisal rights with respect to such shares of
Company Common Stock in accordance with Section 262 of the
DGCL (the “ Dissenting Shares ”) shall not be
canceled and the holder thereof shall not receive the Merger
Consideration as compensation for such cancellation, and the
holders thereof shall be entitled to only such rights as are
granted by Section 262 of the DGCL; provided ,
however , that if any such stockholder of the Company shall
fail to perfect or shall effectively waive, withdraw or lose such
stockholder’s rights under Section 262 of the DGCL, such
stockholder’s Dissenting Shares shall thereupon be deemed to
have been canceled, at the Effective Time, and the holder thereof
shall be entitled to receive the Merger Consideration (payable
without any interest thereon and less the amount of withholding (if
any) that is required to be made under applicable Tax Law) as
compensation for such cancellation.
(b) The
Company shall give Parent (i) prompt notice of any notice
received by the Company of intent to demand appraisal with respect
to any shares of Company Common Stock, withdrawals of such notices
and any other instruments or notices served pursuant to
Section 262 of the DGCL and (ii) the opportunity to direct all
negotiations and proceedings with respect to the exercise of
appraisal rights under Section 262 of the DGCL. The Company
shall not, except with the prior written consent of Parent or as
otherwise required by an order, decree, ruling or injunction of a
court of competent jurisdiction, make any payment or other
commitment with respect to any such exercise of appraisal rights or
offer to settle or settle any such rights.
SECTION 2.04.
Exchange of Certificates .
(a) Prior
to the Effective Time, Parent shall appoint The Bank of New York or
another bank or trust company that is reasonably satisfactory to
the Company to act as paying agent (the “ Paying Agent
”) for the payment of the Merger Consideration. At the
Effective Time, Parent shall deposit, or cause the Surviving
Corporation to deposit, with the Paying Agent, for the benefit of
the holders of Certificates, cash in an amount sufficient to pay
the aggregate Merger Consideration required to be paid pursuant to
Section 2.01(c) (the “ Exchange Fund
”).
(b) As
soon as reasonably practicable after the Effective Time, Parent
shall cause the Paying Agent to mail to each holder of record of a
Certificate whose shares of Company Common Stock were converted
into the right to receive the Merger Consideration (i) a form
of letter of transmittal (which shall specify that delivery shall
be effected, and risk of loss and title to the Certificates shall
pass, only upon proper delivery of the Certificates to the Paying
Agent and which shall be in customary form and contain customary
provisions) and (ii) instructions for use in effecting the
surrender of the Certificates in exchange for the Merger
Consideration. Each holder of record of one or more Certificates
shall, upon surrender to the Paying Agent of such Certificate or
Certificates, together with such letter of transmittal, duly
executed, and such other documents as may reasonably be required by
the Paying Agent, be entitled to receive in exchange therefor the
Merger Consideration for each share of Company Common Stock
formerly represented by such Certificate or Certificates, and the
Certificates so surrendered shall forthwith be canceled. In the
event of a transfer of ownership of Company Common Stock which is
not registered in the transfer records of the Company, payment of
the Merger Consideration in accordance with this
Section 2.04(b) may be made to a person other
- 6 -
than the person
in whose name the Certificate so surrendered is registered if such
Certificate shall be properly endorsed or otherwise be in proper
form for transfer and the person requesting such payment shall pay
any transfer or other Taxes required by reason of the payment of
the Merger Consideration to a person other than the registered
holder of such Certificate or establish to the reasonable
satisfaction of Parent that such Taxes have been paid or are not
applicable. Until surrendered as contemplated by this
Section 2.04(b), each Certificate shall be deemed at any time
after the Effective Time to represent only the right to receive
upon such surrender the Merger Consideration. No interest shall be
paid or accrued for the benefit of holders of the Certificates on
the Merger Consideration payable in respect of the
Certificates.
(c) The
Merger Consideration paid upon the surrender of Certificates in
accordance with the terms of this Article II shall be deemed
to have been paid in full satisfaction of all rights pertaining to
the shares of Company Common Stock formerly represented by such
Certificates. At the close of business on the day on which the
Effective Time occurs, the share transfer books of the Company
shall be closed, and there shall be no further registration of
transfers on the share transfer books of the Surviving Corporation
of the shares of Company Common Stock that were outstanding
immediately prior to the Effective Time. If, after the Effective
Time, any Certificate is presented to the Surviving Corporation for
transfer, it shall be canceled against delivery of the Merger
Consideration as provided in this Article II.
(d) Any
portion of the Exchange Fund that remains undistributed to the
holders of the Certificates for six months after the Effective Time
shall be delivered to Parent, upon demand, and any holders of the
Certificates who have not theretofore complied with this
Article II shall thereafter look only to Parent for, and
Parent shall remain liable for, payment of their claim for the
Merger Consideration in accordance with this
Article II.
(e) None
of Parent, Merger Sub, the Company, the Surviving Corporation or
the Paying Agent shall be liable to any person in respect of any
cash or distributions from the Exchange Fund properly delivered to
a public official pursuant to any applicable abandoned property,
escheat or similar Law. If any Certificate shall not have been
surrendered prior to four years after the Effective Time (or
immediately prior to such earlier date on which any Merger
Consideration would otherwise escheat to or become the property of
any Governmental Entity), any such Merger Consideration shall, to
the extent permitted by applicable Law, become the property of
Parent, free and clear of all claims or interest of any person
previously entitled thereto.
(f) The
Paying Agent shall invest the cash included in the Exchange Fund as
directed by Parent. Any interest and other income resulting from
such investments will be payable to the Surviving Corporation or
Parent, as Parent directs. If for any reason (including losses) the
cash in the Exchange Fund shall be insufficient to fully satisfy
all of the payment obligations to be made by the Paying Agent
hereunder, Parent shall promptly deposit cash into the Exchange
Fund in an amount which is equal to the deficiency in the amount of
cash required to fully satisfy such cash payment
obligations.
(g) If
any Certificate shall have been lost, stolen or destroyed, upon the
making of an affidavit of that fact by the person claiming such
Certificate to be lost, stolen or destroyed and, if required by
Parent, the posting by such person of a bond in such
reasonable
- 7 -
amount as
Parent may direct as indemnity against any claim that may be made
against it with respect to such Certificate, the Paying Agent shall
deliver in exchange for such lost, stolen or destroyed Certificate
the Merger Consideration payable pursuant to this
Article II.
(h) Parent,
the Surviving Corporation or the Paying Agent shall be entitled to
deduct and withhold from the consideration otherwise payable
pursuant to this Agreement such amounts as Parent, the Surviving
Corporation or the Paying Agent are required to deduct and withhold
with respect to the making of such payment under the Code, or any
provision of state, local or foreign Tax Law. To the extent that
amounts are so withheld and paid over to the appropriate Taxing
Authority by Parent, the Surviving Corporation or the Paying Agent,
such withheld amounts shall be treated for all purposes of this
Agreement as having been paid to the holder of Certificates in
respect of which such deduction and withholding was made by Parent,
the Surviving Corporation or the Paying Agent.
REPRESENTATIONS AND WARRANTIES OF
THE COMPANY
Except
as set forth in the disclosure schedule delivered by the Company to
Parent prior to the execution of this Agreement (the “
Company Disclosure Schedule ”) (with specific
reference to the particular Section or subsection of this Agreement
to which the information set forth in such disclosure schedule
relates; provided that information contained in any section
of the Company Disclosure Schedule shall be deemed to be disclosed
with respect to any other section of this Agreement, other than
Section 3.07(a) of this Agreement, to the extent that it is
readily apparent from the face of such disclosure that such
information is applicable to such other section of this Agreement),
the Company represents and warrants to Parent and Merger Sub as
follows:
SECTION 3.01.
Organization, Standing and Corporate Power; Subsidiaries .
(a) The Company and each of its Subsidiaries has been duly
organized, and is validly existing and in good standing (with
respect to jurisdictions that recognize that concept) under the
Laws of the jurisdiction of its incorporation or formation, as the
case may be, and has all requisite power and authority and
possesses all governmental licenses, permits, authorizations and
approvals necessary to enable it to use its corporate or other name
and to own, lease or otherwise hold and operate its properties and
other assets and to carry on its business as currently conducted,
except where the failure to have such governmental licenses,
permits, authorizations or approvals or where the failure of a
Subsidiary of the Company to be in good standing has not had and
would not reasonably be likely to have, individually or in the
aggregate, a Material Adverse Effect. The Company and each of its
Subsidiaries is duly qualified or licensed to do business and is in
good standing (with respect to jurisdictions that recognize that
concept) in each jurisdiction in which the nature of its business
or the ownership, leasing or operation of its properties makes such
qualification, licensing or good standing necessary, other than in
such jurisdictions where the failure to be so qualified, licensed
or in good standing individually or in the aggregate has not had
and would not reasonably be likely to have a Material Adverse
Effect.
(b) Section 3.01(b)
of the Company Disclosure Schedule lists, as of the date hereof,
each Subsidiary of the Company. All of the outstanding capital
stock of, or other equity
- 8 -
interests in,
each Subsidiary of the Company, is directly or indirectly owned by
the Company. All the issued and outstanding shares of capital stock
of, or other equity interests in, each such Subsidiary owned by the
Company have been validly issued and are fully paid and
nonassessable and are owned directly or indirectly by the Company
free and clear of all pledges, liens, charges, encumbrances or
security interests of any kind or nature whatsoever (other than
liens, charges and encumbrances for current Taxes not yet due and
payable) (collectively, “ Liens ”), and free of
any restriction on the right to vote, sell or otherwise dispose of
such capital stock or other equity interests. Except for the
capital stock of, or voting securities or equity interests in, its
Subsidiaries, the Company does not own, directly or indirectly, as
of the date hereof, any capital stock of, or other voting
securities or equity interests in, any corporation, partnership,
joint venture, association or other entity.
SECTION 3.02.
Certificate of Incorporation and Bylaws . The Company has
made available to Parent, prior to the date of this Agreement,
complete and accurate copies of the Company Certificate and the
Company’s Restated By-laws (the “ Company Bylaws
”), and the comparable organizational documents of each
Subsidiary, in each case as amended to the date hereof. The Company
Certificate and Company Bylaws and other organizational documents
of the Company and each Subsidiary are in full force and effect and
no other organizational documents are applicable to or binding upon
the Company.
SECTION 3.03.
Capitalization . (a) The authorized capital stock of
the Company consists of 200,000,000 shares of Company Common Stock,
600,000 shares of non-voting common stock, par value $0.01 per
share (“ Company Non-Voting Common Stock ”), and
20,000,000 shares of preferred stock, no par value (“
Company Preferred Stock ”), of which 1,000,000 of such
shares are designated as Series A Junior Participating
Preferred Stock, without par value, and have been reserved for
issuance upon the exercise of the rights (the “ Company
Rights ”) distributed to the holders of Company Common
Stock pursuant to the Company’s Rights Agreement, dated as of
February 11, 1999, as amended (the “ Company Rights
Plan ”), by and between the Company and American Stock
Transfer & Trust Company, as Rights Agent. At the close of
business on October 31, 2006 (the “ Capitalization
Date ”):
(i)
42,214,521 shares of Company Common Stock were issued and
outstanding (which number includes 2,986,782 shares of Company
Common Stock held by the Company in its treasury);
(ii)
1,896,827 shares of Company Common Stock were reserved for issuance
upon conversion of the Company’s 3.25% Convertible
Subordinated Debentures due 2024 (the “ 2024 Convertible
Debentures ”);
(iii)
7,725,411 shares of Company Common Stock were reserved and
available for issuance upon or otherwise deliverable in connection
with the grant of equity-based awards or the exercise of Company
Stock Options issued pursuant to the Company’s 2006 Long-Term
Incentive Plan, Second Amended and Restated Stock Option Plan,
Non-Qualified Stock Option Plan for Non-Executive Employees,
Non-Qualified Stock Option Plan for Employees of Acquired Companies
and Amended and Restated Non-Employee Director Stock Option Plan
and Deferred Stock Unit Plan, in each case as amended to date (such
plans, collectively, the “ Company Stock Plans
”), of
- 9 -
which
(x) 5,526,213 shares of Company Common Stock were subject to
outstanding Company Stock Options or agreements to grant Company
Stock Options, (y) 399,345 shares of Company Common Stock were
subject to outstanding Company RSUs or agreements to grant Company
RSUs and (z) 126,001 shares of Company Common Stock were
subject to outstanding Company Deferred Stock Units; and
(iv)
no shares of Company Preferred Stock were issued or outstanding or
were held by the Company as treasury shares.
(b) Except
as set forth above in Section 3.03(a), at the close of
business on the Capitalization Date, no shares of capital stock or
other voting securities or equity interests of the Company were
issued, reserved for issuance or outstanding. At the close of
business on the Capitalization Date, (i) no shares of Company
Common Stock were owned by a direct or indirect wholly-owned
Subsidiary of the Company and (ii) there were no outstanding
stock appreciation rights, “phantom” stock rights,
performance units, rights to receive shares of Company Common Stock
on a deferred basis or other rights (other than Company Stock
Options, Company RSUs, Company Deferred Stock Units and the 2024
Convertible Debentures) that are linked to the value of Company
Common Stock (collectively, “ Company Stock-Based
Awards ”). All outstanding shares of capital stock of the
Company are, and all shares which may be issued pursuant to the
Company Stock Options, Company RSUs or Company Deferred Stock Units
will be, when issued in accordance with the terms thereof, duly
authorized, validly issued, fully paid and nonassessable and not
subject to preemptive rights. Except for the 2024 Convertible
Debentures, there are no bonds, debentures, notes or other
indebtedness of the Company having the right to vote (or
convertible into, or exchangeable for, securities having the right
to vote) on any matters on which stockholders of the Company may
vote. Except as set forth above in Section 3.03(a) and for
issuances of shares of Company Common Stock pursuant to the Company
Stock Options, Company RSUs, Company Deferred Stock Units and 2024
Convertible Notes set forth above in Section 3.03(a) or as may
otherwise be permitted under Section 5.01(a), (x) there
are not issued, reserved for issuance or outstanding (A) any shares
of capital stock or other voting securities or equity interests of
the Company, (B) any securities of the Company or any of its
Subsidiaries convertible into or exchangeable or exercisable for
shares of capital stock or other voting securities or equity
interests of the Company or any of its Subsidiaries, (C) any
warrants, calls, options or other rights to acquire from the
Company or any of its Subsidiaries, and no obligation of the
Company or any of its Subsidiaries to issue, any capital stock,
voting securities, equity interests or securities convertible into
or exchangeable or exercisable for capital stock or voting
securities of the Company or (D) any Company Stock-Based
Awards and (y) there are not any outstanding obligations of
the Company or any of its Subsidiaries to repurchase, redeem or
otherwise acquire any such securities or to issue, deliver or sell,
or cause to be issued, delivered or sold, any such securities.
Neither the Company nor any of its Subsidiaries is a party to any
voting Contract with respect to the voting of any such
securities.
(c) Since
January 1, 2001, except as would not reasonably be likely to
have, individually or in the aggregate, a Material Adverse Effect,
with respect to the Company Stock Options: (A) each Company
Stock Option was properly accounted for on the books and records of
the Company; (B) each grant of Company Stock Options was made
in accordance with the terms of the applicable Company Stock Plans
and any applicable Laws and regulatory rules or requirements; and
(C) the per share exercise price of each Company Stock Option
was
- 10 -
determined in
accordance with the applicable Company Stock Plan and, to the
extent required pursuant to the terms of the applicable Company
Stock Plan, was equal to the fair market value of a share of
Company Common Stock (determined in accordance with the applicable
Company Stock Plan) on the applicable date on which the related
grant was by its terms to be effective.
SECTION 3.04.
Authority . The Company has all requisite corporate power
and authority to execute and deliver this Agreement and, subject to
receipt of the Company Stockholder Approval, to consummate the
transactions contemplated by this Agreement. The execution and
delivery of this Agreement by the Company and the consummation by
the Company of the transactions contemplated by this Agreement have
been duly authorized by all necessary corporate action on the part
of the Company and no other corporate proceedings on the part of
the Company are necessary to authorize this Agreement or to
consummate the transactions contemplated by this Agreement (other
than the obtaining of the Company Stockholder Approval). This
Agreement has been duly executed and delivered by the Company and,
assuming the due authorization, execution and delivery by each of
the other parties hereto, constitutes a legal, valid and binding
obligation of the Company, enforceable against the Company in
accordance with its terms, subject to bankruptcy, insolvency,
fraudulent transfer, moratorium, reorganization or similar Laws
affecting the rights of creditors generally and the availability of
equitable remedies (regardless of whether such enforceability is
considered in a proceeding in equity or at law). The Board of
Directors of the Company has unanimously, by resolutions duly
adopted at a meeting duly called and held (i) approved, and
declared advisable, this Agreement, (ii) determined that the
terms of this Agreement are fair to, and in the best interests of,
the Company and its stockholders, (iii) directed that the
Company submit the adoption of this Agreement to a vote at a
meeting of the stockholders of the Company as promptly as
practicable, (iv) subject to Section 6.04, recommended
that the stockholders of the Company adopt this Agreement at the
Stockholders Meeting, which resolutions have not as of the date
hereof been subsequently rescinded, modified or withdrawn in any
way, and (v) approved this Agreement, the Voting Agreement and
the Merger for purposes of Section 203 of the DGCL.
SECTION 3.05.
No Conflict; Required Filings and Consents . (a) The
execution and delivery of this Agreement by the Company do not, and
the consummation by the Company of the Merger and the other
transactions contemplated by this Agreement and compliance by the
Company with the provisions of this Agreement will not, conflict
with, or result in any violation or breach of, or default (with or
without notice or lapse of time, or both) under, or give rise to a
right of, or result in, termination, modification, cancellation or
acceleration of any obligation or to the loss of a benefit under,
or result in the creation of any Lien in or upon any of the
properties or other assets of the Company or any of its
Subsidiaries under, (i) the Company Certificate or the Company
Bylaws or the comparable organizational documents of any of its
Subsidiaries, (ii) any loan or credit agreement, bond,
debenture, note, mortgage, or indenture, or any lease, supply
agreement, license agreement, development agreement or other
contract, agreement, obligation, commitment or instrument (each,
including all amendments thereto, a “ Contract
”), to which the Company or any of its Subsidiaries is a
party or any of their respective properties or other assets is
subject or (iii) subject to obtaining the Company Stockholder
Approval and assuming the consents, approvals, filings and other
matters referred to Section 3.05(b) are duly obtained or made,
any (A) statute, law, ordinance, rule or regulation (domestic
or foreign) issued, promulgated or entered into by or with any
Governmental Entity (each, a “ Law ”) applicable
to
- 11 -
the Company or
any of their respective Subsidiaries or any of their respective
properties or other assets or (B) order, writ, injunction,
decree, judgment or stipulation issued, promulgated or entered into
by or with any Governmental Entity (each, an “ Order
”) applicable to the Company or any of its Subsidiaries or
their respective properties or other assets, other than, in the
case of clauses (ii) and (iii), any such conflicts,
violations, breaches, defaults, rights of termination,
modification, cancellation or acceleration, losses or Liens that
individually or in the aggregate have not had and would not
reasonably be likely to have a Material Adverse Effect.
(b) The
execution, delivery and performance of this Agreement by the
Company and the consummation of the Merger or the other
transactions contemplated by this Agreement by the Company do not
and will not require any consent, approval, order, authorization or
permit of, action by, filing with or notification to, any Federal,
state, local or foreign governmental, any court, administrative,
regulatory or other governmental agency, commission or authority or
any organized securities exchange (each, a “ Governmental
Entity ”), except for (i) (A) the filing of a
premerger notification and report form by the Company under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended,
and the rules and regulations thereunder (the “ HSR
Act ”) and the termination of the waiting period required
thereunder, and (B) the receipt, termination or expiration, as
applicable, of approvals or waiting periods required under any
other applicable Antitrust Law, (ii) the filing with the SEC of
(x) the Proxy Statement and (y) such reports under the
Securities Exchange Act of 1934, as amended (including the rules
and regulations promulgated thereunder, the “ Exchange
Act ”) as may be required in connection with this
Agreement and the transactions contemplated hereby, (iii) the
filing of the Certificate of Merger with the Secretary of State of
the State of Delaware, (iv) any filings with and approvals of
NASDAQ National Market System (“ Nasdaq ”) and
(v) such other consents, approvals, orders, authorizations,
actions, registrations, declarations and filings the failure of
which to be obtained or made individually or in the aggregate would
not reasonably be likely to (x) have a Material Adverse Effect
or (y) prevent or materially impede, interfere with, hinder or
delay the consummation of the transactions contemplated by this
Agreement.
SECTION 3.06.
Company SEC Documents; Financial Statements; No Undisclosed
Liabilities . (a) The Company has timely filed all
reports, schedules, forms, statements and other documents
(including exhibits and other information incorporated therein)
with the Securities and Exchange Commission (the “ SEC
”) required to be filed by the Company since January 1,
2003 (such documents, together with any documents filed (rather
than furnished) during such period by the Company to the SEC on a
voluntary basis on Current Reports on Form 8-K, the “
Company SEC Documents ”). As of its filing date, or if
amended or supplemented prior to the date of this Agreement, as of
the date of the last such amendment or supplement, each of the
Company SEC Documents complied in all material respects with, to
the extent in effect at the time of filing, the requirements of the
Securities Act of 1933, as amended (including the rules and
regulations promulgated thereunder, the “ Securities
Act ”), and the Exchange Act applicable to such Company
SEC Documents. Except to the extent the information contained in
any Company SEC Document has been amended, supplemented or
superseded by a later-filed Company SEC Document filed prior to the
date hereof, none of the Company SEC Documents contains any untrue
statement of a material fact or omits to state a material fact
required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they
were made, not misleading, which individually or in the aggregate
would require an amendment, supplement or correction to such
Company SEC Documents. Each of the
- 12 -
Company SEC
Documents complied in all material respects at the time it was
filed as to form with the applicable requirements and the published
rules and regulations of the SEC with respect thereto in effect at
the time of such filing and the financial statements included
therein or incorporated therein by reference (including the related
notes) were prepared in accordance with generally accepted
accounting principles in the United States (“ GAAP
”) (except, in the case of unaudited statements, as permitted
by the rules and regulations of the SEC) applied on a consistent
basis during the periods involved (except as may be indicated in
the notes thereto) and fairly presented in all material respects
the consolidated financial position of the Company and its
consolidated Subsidiaries as of the dates thereof and the
consolidated results of their operations and cash flows for the
periods then ended (subject, in the case of unaudited statements,
to normal recurring year-end audit adjustments).
(b) Neither
the Company nor any of its Subsidiaries has any liability or
obligation of any nature (whether accrued, absolute, contingent or
otherwise) which if known would be required to be reflected,
reserved for or disclosed in a consolidated balance sheet of the
Company and its consolidated Subsidiaries, including the notes
thereto, prepared as of the date of this Agreement in accordance
with GAAP, except (i) as reflected, reserved for or disclosed
in the most recent balance sheet of the Company included in Company
SEC Documents filed prior to the date of this Agreement (the
“ Filed Company SEC Documents ”), (ii) as
incurred in the ordinary course of business consistent with past
practice since June 30, 2006, (iii) as incurred pursuant
to the Transactions or (iv) as has not had and would not
reasonably be likely to have, individually or in the aggregate, a
Material Adverse Effect. Neither the Company nor any of its
Subsidiaries is a party to, or has any commitment to become a party
to, any joint venture, off-balance sheet partnership or any similar
Contract or arrangement (including any Contract or arrangement
relating to any transaction or relationship between or among the
Company and any of its Subsidiaries, on the one hand, and any
unconsolidated Affiliate, including any structured finance, special
purpose or limited purpose entity or person, on the other hand, or
any “off- balance sheet arrangement” (as defined in
Item 303(a) of Regulation S-K of the SEC)), where the result,
purpose or intended effect of such Contract or arrangement is to
avoid disclosure of any material transaction involving, or material
liabilities of, the Company or any of its Subsidiaries in the
Company’s or such Subsidiary’s published financial
statements or other Company SEC Documents. None of the Subsidiaries
of the Company are, or have at any time since January 1, 2003
been, subject to the reporting requirements of Section 13(a) or
15(d) of the Exchange Act.
(c) Each
of the principal executive officer of the Company and the principal
financial officer of the Company (or each former principal
executive officer of the Company and each former principal
financial officer of the Company, as applicable) has made all
certifications required by Rule 13a-14 or 15d-14 under the Exchange
Act and Sections 302 and 906 of the Sarbanes-Oxley Act of 2002
(including the rules and regulations promulgated thereunder,
“ SOX ”) with respect to the Company SEC
Documents, and the statements contained in such certifications are
true and accurate. For purposes of this Agreement, “principal
executive officer” and “principal financial
officer” shall have the meanings given to such terms in SOX.
Neither the Company nor any of its Subsidiaries has outstanding, or
has arranged any outstanding, “extensions of credit” to
directors or executive officers within the meaning of
Section 402 of SOX.
- 13 -
(d) The
Company’s disclosure controls and procedures (as defined in
Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are
designed to provide reasonable assurance that the information
relating to the Company, including its consolidated subsidiaries,
required to be disclosed by the Company in its reports that it
files or submits under the Exchange Act is recorded, processed,
summarized and reported within the time periods specified in the
rules and forms of the SEC. The Company maintains internal control
over financial reporting (as defined in Rules 13a-15(f) and
15d-15(f) under the Exchange Act) sufficient to provide reasonable
assurance that (A) transactions are recorded as necessary to
permit preparation of financial statements in accordance with GAAP,
and that receipts and expenditures of the company are being made
only in accordance with authorizations of management and directors
of the Company; (B) access to assets is permitted only in
accordance with management’s general or specific
authorizations; and (C) the recorded accountability for assets
is compared with existing assets at reasonable intervals and
appropriate action is taken with respect to any material
differences. To the extent required by applicable Law, (i) the
Company has evaluated the effectiveness of the Company’s
disclosure controls and procedures and presented in any applicable
Company SEC Document that is a report on Form 10-K or Form 10-Q or
any amendment thereto its conclusions about the effectiveness of
the disclosure controls and procedures as of the end of the period
covered by such report or amendment based on such evaluation, and
(ii) disclosed in such report or amendment any change in the
Company’s internal control over financial reporting that
occurred during the period covered by such report or amendment that
has materially affected, or is reasonably likely to materially
affect, the Company’s internal control over financial
reporting.
(e) Since
January 1, 2003, (i) neither the Company nor any of its
Subsidiaries, nor, to the Knowledge of the Company, any director,
officer, employee, auditor, accountant or representative of the
Company or any of its Subsidiaries has received knowledge of any
material complaint, allegation, assertion or claim, whether written
or oral, regarding the accounting or auditing practices,
procedures, methodologies or methods of the Company or any of its
Subsidiaries or their respective internal accounting controls,
including any material complaint, allegation, assertion or claim
that the Company or any of its Subsidiaries has engaged in improper
accounting or auditing practices, and (ii) no attorney
representing the Company or any of its Subsidiaries, whether or not
employed by the Company or any of its Subsidiaries, has reported
evidence of a material violation of securities laws, breach of
fiduciary duty or similar violation by the Company or any of its
Subsidiaries or their respective officers, directors, employees or
agents to the Board of Directors of the Company or any committee
thereof or to any director or officer of the Company.
SECTION 3.07.
Absence of Certain Changes or Events . (a) Since
June 30, 2006, there has not been any change, event,
condition, development or occurrence which has had, or would
reasonably be likely to have, individually or in the aggregate, a
Material Adverse Effect.
(b) Except
for liabilities incurred in connection with this Agreement or, with
respect to liabilities incurred after the date hereof, as expressly
permitted pursuant to Section 5.01, since June 30, 2006,
the Company and its Subsidiaries have conducted their respective
businesses only in the ordinary course consistent with past
practice, and from such date until the date hereof there has not
been:
- 14 -
(i)
any declaration, setting aside or payment of any dividend or other
distribution (whether in cash, stock or property) with respect to
any capital stock of the Company or any of its Subsidiaries, other
than dividends or distributions by a direct or indirect
wholly-owned Subsidiary of the Company to the Company or another
direct or indirect wholly-owned Subsidiary of the
Company;
(ii)
any purchase, redemption or other acquisition by the Company or any
of its Subsidiaries of any shares of capital stock or any other
securities of the Company or any of its Subsidiaries or any
options, warrants, calls or rights to acquire such shares or other
securities;
(iii)
any split, combination or reclassification of any capital stock of
the Company or any of its Subsidiaries or any issuance or the
authorization of any issuance of any other securities in respect
of, in lieu of or in substitution for shares of their respective
capital stock;
(iv)
(iv) (A) any granting by the Company or any of its
Subsidiaries to any current or former director, officer, employee,
independent contractor or consultant of the Company or any of its
Subsidiaries (all such individuals, collectively, the “
Company Personnel ”) of any increase in compensation,
bonus or fringe or other benefits, except for normal increases in
cash compensation (including cash bonus compensation) in the
ordinary course of business consistent with past practice or as was
required under any Company Benefit Agreement or Company Benefit
Plan, (B) any granting by the Company or any of its
Subsidiaries to any Company Personnel of (x) any increase in
severance or termination pay or (y) any right to receive any
severance or termination pay, (C) any entry by the Company or
any of its Subsidiaries into, or any amendments of, (x) any
employment, deferred compensation, consulting, severance, change of
control, termination, retention, deal bonus or indemnification
Contract with any Company Personnel or (y) any Contract with
any Company Personnel the benefits of which are contingent, or the
terms of which are materially altered, upon the occurrence of a
transaction involving the Company of a nature contemplated by this
Agreement (all such Contracts under this clause (C), collectively,
“ Company Benefit Agreements ”), or (D) the
adoption, amendment or termination of any Company Benefit Plan or
entry into any agreement, plan or arrangement to do any of the
foregoing;
(v)
any material damage, destruction or loss, whether or not covered by
insurance;
(vi)
any change in accounting methods, principles or practices by the
Company materially affecting its assets, liabilities or businesses,
except insofar as may have been required by a change in GAAP;
or
(vii)
any material Tax election or any settlement or compromise of any
material income Tax liability.
SECTION 3.08.
Litigation . Except for those matters that individually or
in the aggregate have not had and would not reasonably be likely to
have a Material Adverse Effect: (a) there are no actions, suits,
claims, hearings, proceedings, arbitrations, mediations,
audits,
- 15 -
inquiries or
investigations (whether civil, criminal, administrative or
otherwise) (“ Actions ”), including Actions
under or relating to any Environmental Law, pending or, to the
Knowledge of the Company, threatened against the Company or any of
its Subsidiaries; (b) neither the Company nor any of its
Subsidiaries nor any of their respective properties or assets is or
are subject to any Order, writ, judgment, injunction, settlement,
decree or award; and (c) to the Knowledge of the Company,
there are no formal or informal governmental inquiries or
investigations or internal investigations or whistle-blower
complaints pending or threatened, in each case regarding accounting
or disclosure practices of the Company or any of its Subsidiaries,
compliance by the Company or any of its Subsidiaries with any Law
or any malfeasance by any officer of the Company or any of its
Subsidiaries.
SECTION 3.09.
Material Contracts . (a) For purposes of this
Agreement, a “ Material Contract ”) shall
mean:
(i)
Any employment, severance, retention, deal bonus, consulting or
other Contract with any Company Personnel which will require the
payment of amounts by the Company or any of its Subsidiaries, as
applicable, after the date hereof in excess of $150,000 per
annum;
(ii)
Any collective bargaining agreement with any labor
union;
(iii)
Any Contract for capital expenditures or the acquisition or
construction of fixed assets which requires aggregate future
payments in excess of $500,000;
(iv)
Any Contract, other than the Company Certificate, Company Bylaws or
other corporate documents of the Company and its Subsidiaries,
containing covenants of the Company or any of its Subsidiaries to
indemnify or hold harmless another person or group of persons,
unless such indemnification or hold harmless obligation to such
person, or group of persons, as the case may be, would not
reasonably be expected to exceed a maximum of $500,000;
(v)
Any Contract requiring aggregate future payments or expenditures in
excess of $500,000 and relating to corrective cleanup, abatement,
remediation or similar actions in connection with environmental
liabilities or obligations;
(vi)
Company IP Agreements;
(vii)
Any Contract pursuant to which the Company or any of its
Subsidiaries has entered into a partnership or joint venture with
any other person (other than the Company or any of its
Subsidiaries);
(viii)
Any (i) indenture, mortgage, loan, guarantee or credit
Contract under which the Company or any of its Subsidiaries has
outstanding indebtedness or any outstanding note, bond, indenture
or other evidence of indebtedness for borrowed money or otherwise
or (ii) guaranteed indebtedness for money borrowed by others, in
each case, for or guaranteeing an amount in excess of
$500,000;
- 16 -
(ix)
Any Contracts (i) providing for any “off-balance sheet
arrangement” (as defined in Item 303(a) of
Regulation S-K promulgated pursuant to the Securities Act)
where the result, purpose or effect of such Contract is to avoid
disclosure of any material transaction involving or material
liabilities of the Company or any of its Subsidiaries in the
Company’s published financial statements or other Company SEC
Documents or (ii) providing for any loan by the Company or any
of its Subsidiaries to the counterparty to such Contract (or to an
affiliate of such counterparty) for an amount in excess of
$250,000;
(x)
Any Contract (i) containing a covenant that prohibits or
restricts, in any material respect, the Company or any of its
Subsidiaries from engaging in any business activities in any
geographic area, line of business or customer segment or otherwise
in competition with any Person, or (ii) that grants material
exclusivity rights or “most favored nations” status to
the counterparty thereof;
(xi)
Contracts providing for “earn-outs,” “performance
guarantees” or other similar contingent payments by the
Company or any Subsidiary which would reasonably be expected to be
in excess of $500,000 during any twelve-month period;
(xii)
Any Government Contract or Government Bid, other than any such
Government Contract or Government Bid that is with a
Government-owned hospital or ambulance service and that would not
reasonably be expected to involve payments by or to the Company or
any Subsidiary of the Company in excess of $250,000 per
annum;
(xiii)
Any material Contract (including guarantees) between the Company or
any wholly-owned Subsidiary of the Company, on the one hand, and
another Subsidiary of the Company that is not wholly-owned by the
Company, on the other hand;
(xiv)
Any Contract entered into on or after January 1, 2001 relating
to the acquisition or disposition of any business or any assets
(whether by merger, sale of stock or assets or otherwise) in an
amount in excess of $500,000 to the extent that there are
continuing obligations thereunder as of the date hereof;
and
(xv)
Any Contract (other than Contracts of the type described in
subclauses (i) through (xiv) above) that involves
aggregate payments by or to the Company or any of its Subsidiaries
in excess of $500,000 per annum, other than purchase or sales
orders or other Contracts entered into in the ordinary course of
business consistent with past practice that are terminable or
cancelable by the Company or any of its Subsidiaries without
penalty on 90 days’ notice or less.
(b) Section 3.09(a)
of the Company Disclosure Schedule sets forth a list of all
Material Contracts as of the date of this Agreement. Each such
Material Contract is in full force and effect, and neither the
Company nor any of its Subsidiaries has repudiated or waived any
material provision of such Material Contract, except to the extent
that (i) such Material Contract has previously expired in
accordance with its terms or (ii) the failure to be in full
force and effect, or any such repudiation or waiver, individually
or in the aggregate, has not had and would not reasonably be likely
to have a Material Adverse Effect. Neither the Company nor any of
its Subsidiaries, nor, to the Company’s Knowledge, any
counterparty to any such Material Contract,
- 17 -
has violated or
is alleged to have violated any provision of, or committed or
failed to perform any act which, with or without notice, lapse of
time or both, would constitute a default under the provisions of
any such Material Contract, except in each case for those
violations and defaults which, individually or in the aggregate,
has not had and would not reasonably be likely to have a Material
Adverse Effect.
SECTION 3.10.
Government Contracts . (a) (i) During the last three
years, the Company has complied with all U.S. federal Laws and
Regulations applicable to government contracting and procurement,
including U.S. federal Laws and Regulations relating to procurement
integrity, equal employment opportunity and the prohibitions on
false claims and statements in connection with the bidding for,
responding to requests for proposals for, solicitation, negotiation
and execution of Government Contracts, except, in each case, where
the failure to comply individually or in the aggregate has not had
and would not reasonably be likely to have a Material Adverse
Effect, and (ii) during the last three years, none of the
Company, any of its Subsidiaries, or to the Knowledge of the
Company, any of the employees of the Company or any of its
Subsidiaries has made a voluntary disclosure with respect to any
alleged irregularity, misstatement or omission arising under or
relating to a Government Contract or Government Bid, other than
routine inquiries, audits and reconciliations that, in each case,
individually or in the aggregate has not had and would not
reasonably be likely to have a Material Adverse Effect. For
purposes of this Agreement, “ Government Contract
” means any Contract that (x) is between the Company or
any of its Subsidiaries, on the one hand, and a Governmental
Entity, on the other hand, or (y) is entered into by the
Company or any of its Subsidiaries as a subcontractor (at any tier)
known by the Company or any Subsidiary to be in connection with a
contract between another entity and a Governmental Entity, and
“ Government Bid ” means any offer to sell
products or services made by the Company or any of its Subsidiaries
to a Governmental Entity.
(b) Neither
the Company nor any of its Subsidiaries nor any of the Company
Personnel is (or during the last three years has been) or, to the
Knowledge of the Company, is threatened to be suspended or debarred
from doing business with a Governmental Entity or is (or during
such period was) the subject of a finding of non-responsibility or
ineligibility for U.S. Government or non-U.S. Government
contracting.
SECTION 3.11.
Permits; Compliance with Laws . (a) The Company and
each of its Subsidiaries has in effect all approvals,
authorizations, certificates, filings, franchises, licenses,
notices and permits of or with all Governmental Entities and third
persons necessary for it to own, lease or operate its properties
and other assets and to carry on its business and operations as
currently conducted (collectively, “ Permits ”),
except where the failure to have any of such Permits has not had
and would not reasonably be likely to have, individually or in the
aggregate, a Material Adverse Effect. Since January 1, 2003,
there has occurred no default under, or violation of, any such
Permit, except for any such default or violation that has not had
and would not reasonably be likely to have, individually or in the
aggregate, a Material Adverse Effect. The consummation of the
Merger, in and of itself, would not cause any revocation,
modification or cancellation of any such Permit that would
reasonably be likely to have, individually or in the aggregate, a
Material Adverse Effect.
(b) The
businesses of the Company and its Subsidiaries have been and are
being conducted in compliance with, and none of the Company, any
Subsidiary or, to the
- 18 -
Knowledge of
the Company, any of their respective officers, directors or
employees has engaged in any activity which is in violation of,
applicable Laws and Orders, including: (i) the applicable
Medicare and Medicaid fraud and abuse provisions of the federal
Social Security Act and other federal laws, including any activity
which is prohibited under the Federal Anti-Kickback Statute (42
U.S.C. § 1320a-7b, et seq.); (ii) the physician
self-referral provisions of the Stark Law (42 U.S.C. §
1395nn); (iii) the False Claims Act (31 U.S.C. § 3729);
(iv) the Civil Monetary Penalties Law (42 U.S.C. §
1320a-7a); (v) Mail and Wire Fraud (18 U.S.C. §§
1341-1343); (vi) False Statements Relating to Health Care
Matters (18 U.S.C. § 1035); (vii) Health Care Fraud (18
U.S.C. § 1347); (viii) or any applicable regulations
related to any of the above (i) through (vii) (or any
applicable related state or local statutes, regulations, or
ordinances); and (viii) the applicable provisions of the
Health Insurance Portability and Accountability Act of 1996
(“ HIPAA ”), Pub. L. No. 104-191, as
amended, and any rules or regulations promulgated thereunder
regarding the transactions, code sets and unique identifier
requirements (as set forth in 45 C.F.R. Part 162), the privacy
and security of protected health information (as set forth at 45
C.F.R. Part 160 and Part 164, Subparts A, C, and E) and
any state or local statutes, regulations, or ordinances related to
the privacy or security of individually identifiable health or
medical information, except where any such non-compliance has not
had and would not reasonably be likely to have, individually or in
the aggregate, a Material Adverse Effect. Neither the Company nor
any of its Subsidiaries is currently, nor has ever been, a party or
subject to the terms of a corporate integrity agreement required by
the Office of Inspector General of the Department of Health and
Human Services or similar agreement or consent order of any other
Governmental Entity which, in each case, has or could have a
continuing impact on the Company or its Subsidiaries.
(c) Neither
the Company nor any of its Subsidiaries nor, to the Knowledge of
the Company, any of their respective officers, directors, or
employees has been convicted of, charged with or investigated for a
Medicare, Medicaid or state health program related offense or has
been debarred, excluded or suspended from participation in
Medicare, Medicaid or any other federal or state health program, as
defined in 42 U.S.C. §1320a-7b(f) (“ Federal Health
Care Program ”), or been subject to any order or consent
decree of, or criminal or civil fine or penalty relating to a
Federal Health Care Program imposed by, any Governmental Entity. To
the Knowledge of the Company, neither the Company nor any of its
Subsidiaries nor any their officers, directors, employees or
subcontractors has arranged or contracted with (by employment or
otherwise) any individual or entity that is excluded from
participation in a Federal Health Care Program for the provision of
items or services for which payment may be made under such Federal
Health Care Program. To the Knowledge of the Company, no exclusion,
suspension, or debarment claims, actions, proceedings or
investigations are pending or threatened against the Company or any
of its Subsidiaries, or any of their officers, directors, employees
or subcontractors.
(d) The
Company and its Subsidiaries to the extent required by applicable
Healthcare Information Laws, (i) has undertaken all surveys,
audits, inventories, reviews, analyses or assessments (including
any necessary risk assessments), (ii) has developed a plan for
maintaining compliance with all Healthcare Information Laws (the
“ Company Compliance Plan ”) and (iv) has
implemented the Company Compliance Plan in all material respects.
For purposes of this Agreement, the term “ Healthcare
Information Laws ” means any and all Laws
- 19 -
relating to
patient or individual healthcare information, including the
Administrative Simplification requirements of HIPAA.
(e) Each
Subsidiary that is a “covered entity” or “Health
Care Clearinghouse,” as those terms are defined under HIPAA
is in compliance in all material respects with the applicable HIPAA
requirements regarding the privacy and security of protected health
information. Neither the Company nor any such Subsidiary has
received any written notice from any person regarding its or any of
their agents, employees or contractors’ uses or disclosures
of, or security practices regarding, individually identifiable
health-related information in violation of any applicable
Healthcare Information Law, except for such notices which do not
and could not have a continuing impact on the Company or its
Subsidiaries. To the Knowledge of the Company, there is no misuse,
or improper disclosure or successful security incident (each as
determined by reference to the Standards for Privacy of
Individually Identifiable Health Information (45 CFR Part 160
and Part 164, Subparts A and E), the Security Standards for the
Protection of Electronic Protected Health Information (45 CFR
Part 164, Subparts A and C) or state Law, as applicable),
involving individually identifiable health-related information by,
or in the case of Security Incidents (as defined at 45 CFR §
164.304) involving electronic individually identifiable
health-related information held by, the Company or its Subsidiaries
or any of their agents, employees or contractors, involving
individually identifiable health-related information that has not
been remedied as required by applicable Law.
SECTION 3.12.
Environmental Matters . (a) Except for those matters
that individually or in the aggregate have not had and would not
reasonably be likely to have a Material Adverse Effect:
(i) during the period of ownership or operation by the Company
or any of its Subsidiaries of any of its currently or formerly
owned, leased or operated properties or facilities, there have been
no Releases of Hazardous Materials in, on, under, from or affecting
any properties or facilities which would subject the Company or any
of its Subsidiaries to any liability under any Environmental Law or
require any expenditure by the Company or any of its Subsidiaries
thereunder for remediation; (ii) prior to and after, as
applicable, the period of ownership or operation by the Company or
any of its Subsidiaries of any of its currently or formerly owned,
leased or operated properties or facilities, to the Knowledge of
the Company, there were no Releases of Hazardous Materials in, on,
under, from or affecting any properties or facilities which would
subject the Company or any of its Subsidiaries to any liability
under any Environmental Law or require any expenditure by the
Company or any of its Subsidiaries thereunder for remediation;
(iii) neither the Company nor any of its Subsidiaries is subject to
any indemnity obligation or other Contract with any person relating
to obligations or liabilities under Environmental Laws; and (iv) to
the Knowledge of the Company, there are no facts, circumstances or
conditions that would reasonably be expected to form the basis for
any Action or liability against or affecting the Company or any of
its Subsidiaries relating to or arising under Environmental
Laws.
(b) For
the purposes of this Agreement, the following terms shall have the
meanings assigned below:
(i)
“ Environmental Laws ” means all applicable
Federal, state, local and foreign Laws (including the common law),
Orders, notices, Permits or binding Contracts issued, promulgated
or entered into by any Governmental Entity, relating in
- 20 -
any way to the
environment, preservation or reclamation of natural resources or
the presence, management, Release of, or exposure to, Hazardous
Materials, or to human health and safety.
(ii)
“ Hazardous Materials ” means
(A) petroleum, petroleum products and by-products, asbestos
and asbestos-containing materials, urea formaldehyde foam
insulation, electronic, medical or infectious wastes,
polychlorinated biphenyls, radon gas, radioactive substances,
chlorofluorocarbons and all other ozone-depleting substances and
(B) any other chemical, material, substance, waste, pollutant
or contaminant that could result in liability under, or that is
prohibited, limited or regulated by or pursuant to, any
Environmental Law.
(iii)
“ Release ” means any actual or threatened
spilling, leaking, pumping, pouring, emitting, emptying,
discharging, injecting, escaping, leaching, dumping, disposing or
arranging for disposal or migrating into or through the environment
or any natural or man-made structure.
SECTION 3.13.
Labor Relations and Other Employment Matters . (a) As
of the date of this Agreement, none of the employees of the Company
or any of its Subsidiaries are represented by any union with
respect to their employment by the Company or such Subsidiary, and
no labor organization or group of employees of the Company or any
of its Subsidiaries has made a pending demand for recognition or
certification to the Company or any of its Subsidiaries and, to the
Knowledge of the Company, there are no representation or
certification proceedings or petitions seeking a representation
proceeding presently pending or threatened to be brought or filed
with the National Labor Relations Board or any other labor
relations tribunal or authority (foreign or domestic). Since
January 1, 2003, neither the Company nor any of its
Subsidiaries has experienced any material labor disputes, union
organization attempts or work stoppages, slowdowns or lockouts due
to labor disagreements.
(b) Except
as would not, individually or in the aggregate, reasonably be
likely to have a Material Adverse Effect (i) no unfair labor
practice charges, grievances or complaints are pending or, to the
Knowledge of the Company, threatened against the Company or any of
its Subsidiaries, (ii) no employee of the Company at the
officer level or above has given written notice to the Company or
any of its Subsidiaries that any such employee intends to terminate
his or her employment with the Company or any of its Subsidiaries,
(iii) to the Knowledge of the Company, no employee or former
employee of the Company or any of its Subsidiaries is in any
respect in violation of any term of any employment contract,
nondisclosure agreement (including any agreement relating of trade
secrets or proprietary information) or non-competition agreement
with the Company or any of its Subsidiaries, and (iv) the
Company and its Subsidiaries are in compliance with all applicable
Laws, Contracts, policies, plans and programs relating to
employment, employment practices, compensation, benefits, hours,
terms and conditions of employment and the termination of
employment, including any obligations pursuant to the Worker
Adjustment and Retraining Notification Act of 1988.
SECTION 3.14.
ERISA Compliance . (a) Section 3.14(a) of the
Company Disclosure Schedule contains a complete and accurate list,
as of the date hereof, of each “employee benefit plan”
(within the meaning of Section 3(3) of the Employee Retirement
Income Security Act of
- 21 -
1974, as
amended (“ ERISA ”) including multiemployer
plans within the meaning of Section 3(37) of ERISA) and all
employment, employee loan, collective bargaining, bonus, pension,
profit sharing, deferred compensation, incentive compensation,
stock ownership, stock purchase, stock appreciation, restricted
stock, stock option, “phantom” stock, restricted stock
unit, deferred stock unit, retirement, thrift savings, stock bonus,
paid time off, material fringe benefit, vacation, severance,
retention, change in control, and all other material employee
benefit plans, programs, policies or Contracts maintained,
contributed to or required to be maintained or contributed to by
the Company or any of its Subsidiaries or any other person that,
together with the Company, is treated as a single employer under
Section 414(b), (c), (m) or (o) of the Code (each, a
“ Commonly Controlled Entity ”) (exclusive of
any such plan, program, policy or Contract mandated by and
maintained solely pursuant to applicable Law), in each case
providing benefits to any Company Personnel (collectively, but
exclusive of individual option, restricted stock unit and deferred
stock unit award agreements issued under the Company Stock Plans,
the “ Company Benefit Plans ”) and each Company
Benefit Agreement (exclusive of local offer letters mandated under
applicable non-U.S. Law that do not impose any severance
obligations other than any mandatory statutory severance). Each
Company Benefit Plan that is an “employee pension benefit
plan” (as defined in Section 3(2) of ERISA) is sometimes
referred to herein as a “ Company Pension Plan ”
and each Company Benefit Plan that is an “employee welfare
benefit plan” (as defined in Section 3(1) of ERISA) is
sometimes referred to herein as a “ Company Welfare
Plan ”.
(b) The
Company has provided to Parent current, complete and accurate
copies of (i) each Company Benefit Plan, including Company
Benefit Plans maintained primarily for the benefit of individuals
regularly employed outside the United States (“ Foreign
Benefit Plans ”), and Company Benefit Agreements
(exclusive of local offer letters mandated under applicable
non-U.S. Law that do not impose any severance obligations other
than any mandatory statutory severance), (ii) for the two most
recent years (A) annual reports on Form 5500 required to
be filed with the Internal Revenue Service (the “ IRS
”) or any other Governmental Entity with respect to each
Company Benefit Plan (if any such report was required) and all
schedules and attachments thereto, and (B) actuarial valuation
reports, (iii) the most recent summary plan description for
each Company Benefit Plan for which such summary plan description
is required, (iv) each trust Contract and insurance or group
annuity Contract relating to any Company Benefit Plan and
(iv) the most recent favorable IRS determination letter, to
the extent applicable.
(c) Each
Company Benefit Plan has been administered in all material respects
in accordance with its terms except where the failure to comply
with the applicable terms of the plan is necessary to comply with
applicable Law. The Company, its Subsidiaries and all the Company
Benefit Plans and Foreign Benefit Plans are in compliance in all
material respects with the applicable provisions of ERISA, the Code
and all other applicable Laws.
(d) All
Company Pension Plans intended to be qualified within the meaning
of Section 401(a) of the Code have received favorable determination
letters or opinion letters from the IRS, to the effect that such
Company Pension Plans are so qualified and exempt from Federal
income Taxes under Sections 401(a) and 501(a), respectively, of the
Code, no such determination letter has been revoked (nor, to the
Knowledge of the Company, has revocation been threatened) and to
the Knowledge of the Company, no event has occurred since the date
of the most recent determination letter or opinion letter relating
to any such Company Pension Plan
- 22 -
that would
reasonably be likely to adversely affect the qualification of such
Company Pension Plan or materially increase the costs relating
thereto or require security under Section 307 of ERISA. The
Company has provided to Parent a complete and accurate list of all
amendments to any Company Pension Plan as to which a favorable
determination letter or opinion letter has not yet been
received.
(e) Neither
the Company nor any Commonly Controlled Entity has, during the
six-year period ending on the date hereof, maintained, contributed
to or been required to contribute to any Company Pension Plan that
is subject to Title IV of ERISA or Section 412 of the Code, or
any “multiemployer plan” as defined in
Section 3(37) or 4001(a)(3) of ERISA. Except as has not had
and would not reasonably be likely to have a Material Adverse
Effect, neither the Company nor any Commonly Controlled Entity has
any unsatisfied liability under Title IV of ERISA. To the Knowledge
of the Company, no condition exists that presents a material risk
to the Company or any Commonly Controlled Entity of incurring a
material liability under Title IV of ERISA. The Pension Benefit
Guaranty Corporation has not instituted proceedings under
Section 4042 of ERISA to terminate any Company Benefit Plan
and, to the Knowledge of the Company, no condition exists that
presents a material risk that such proceedings will be instituted.
No event has occurred, and to the Knowledge of the Company no
condition exists with respect to or in connection with any Company
Benefit Plan, that would be reasonably likely to subject the
Company, any Subsidiary or Commonly Controlled Entity, to any
material Tax, fine, Lien, penalty or other liability imposed by
ERISA or the Code.
(f) Except as
has not had and would not reasonably be likely to have a Material
Adverse Effect, (A) all reports, returns and similar documents
with respect to all Company Benefit Plans required to be filed with
any Governmental Entity or distributed to any Company Benefit Plan
participant have been duly and timely filed or distributed,
(B) none of the Company or any of its Subsidiaries has
received notice of and, to the Knowledge of the Company, there are
no Actions by any Governmental Entity with respect to, termination
proceedings or other claims (except claims for benefits payable in
the normal operation of the Company Benefit Plans), suits or
proceedings against or involving any Company Benefit Plan or
asserting any rights or claims to benefits under any Company
Benefit Plan that are pending or threatened that could reasonably
be expected to give rise to any material liability, (C) to the
Knowledge of the Company, there are not any facts that could give
rise to any liability in the event of any such Action and
(D) no written or oral communication has been received from
the Pension Benefit Guaranty Corporation in respect of any Company
Benefit Plan subject to Title IV of ERISA in connection with the
transactions contemplated herein.
(g) Except as
has not had and would not reasonably be likely to have a Material
Adverse Effect, (A) all contributions, premiums and
benefit
|